State guides · August 19, 2026

Tennessee Dermatology Billing: Palmetto GBA & TennCare

Navigate Palmetto GBA LCDs and overcome TennCare MCO destruction frequency limits with targeted billing workflows for Tennessee dermatology practices.

By Michael Brennan · Vice President, Payer RelationsMedically-coded review by Sarah Whitfield, CPC, CPMAPublished Last reviewed 4 min readTN

Dermatology practices in Tennessee navigate a distinct payer landscape shaped by Palmetto GBA's Medicare administrative policies and highly restrictive TennCare Medicaid managed care organizations (MCOs). While Medicare fee-for-service establishes strict medical necessity thresholds under Palmetto's local coverage determinations, TennCare plans frequently enforce aggressive destruction limits and frequency caps that trigger automatic denials. Without structured, plan-specific tracking workflows, practices face recurring administrative write-offs and delayed cash flow across both benign and premalignant lesion treatments.

Palmetto GBA Requirements for Tennessee Dermatology

Palmetto GBA serves as the Medicare Administrative Contractor (MAC) for Jurisdiction M, governing Part B claims in Tennessee. For dermatology clinics, Palmetto's local coverage policies dictate precise documentation standards for minor surgical procedures, lesion destructions, and evaluation and management (E/M) unbundling.

Key documentation requirements under Palmetto GBA include:

  • Benign Lesion Removal (CPT 11400–11446, 17110): Palmetto does not cover the destruction or excision of benign lesions for cosmetic purposes. Medical necessity must be established in the clinical record before the procedure takes place. Accepted clinical indications include bleeding, recurrent trauma, chronic irritation from clothing, intense pruritus, or physical obstruction of vision or orifices. The note must specify the exact anatomical location, size, and symptoms attributed directly to the lesion.
  • Premalignant Lesion Destruction (CPT 17000, 17003, 17004): Destruction of actinic keratoses requires distinct anatomic site recording and lesion counts in the operative note. Billing CPT 17004 requires documentation supporting the treatment of 15 or more distinct lesions in a single encounter.
  • Modifier 25 Utilization: Palmetto audits the same-day billing of an E/M service (such as CPT 99213 or 99214) with a minor surgical procedure (such as a biopsy, CPT 11102, or destruction, CPT 17000). The E/M note must substantiate a problem-oriented evaluation that is completely distinct from the routine pre-procedure and post-procedure work inherent to the surgery.

The TennCare MCO Denial Pattern: Destruction Frequency Limits

While Medicare audits focus heavily on clinical indication and Modifier 25 validity, the most prevalent source of clinical denials for Tennessee dermatology clinics stems from TennCare MCOs—including BlueCare, Amerigroup (Wellpoint), and UnitedHealthcare Community Plan.

TennCare MCOs routinely enforce rigid frequency limits on destructive modalities (CPT 17000–17004 and CPT 17110–17111). These plans often establish annual utilization thresholds per member, capping the number of payable destruction sessions within a rolling 12-month period or a plan year, regardless of clinical recurrence.

Common failure points in Tennessee practices include:

  • Exceeding Rolling-Year Caps: When a patient undergoes cryotherapy for actinic keratoses or verrucae multiple times across a calendar year, TennCare MCO adjudication engines automatically deny subsequent lines as exceeding plan-specific benefit limits.
  • Unbundling Lesion Counts: Submitting multiple line items or repeating initial destruction codes (CPT 17000) within the same benefit cycle triggers automatic claim rejections.
  • Lack of Prior Authorization for High-Volume Destruction: Certain TennCare plans require prior authorization or formal clinical review when treating widespread actinic damage exceeding specific lesion counts or when performing subsequent sessions within short intervals.

When billing teams submit these claims without cross-referencing prior utilization within the benefit window, the practice absorbs the cost through preventable administrative denials.

Revenue Cycle Controls: Frequency Tracking Per Patient, Per Plan Year

Eliminating frequency-based denials requires front-end and billing-level controls that monitor patient utilization across payer-specific benefit periods. Dermatology practices operating in Tennessee must implement systematic tracking mechanisms before treatment occurs.

Managing payer variances across the state requires a structured approach to Tennessee dermatology billing and coding that aligns front-office scheduling with clinical workflows.

1. Configure Practice Management Rule Engines

Update your practice management (PM) and billing software with custom rules tailored to TennCare MCO contracts. Configure alerts that flag CPT codes 17000, 17003, 17004, 17110, and 17111 when billed for an MCO enrollee if a prior destruction claim was submitted within the preceding 12 months.

2. Establish a Destruction Log and History Verification

Front-desk and clinical staff must verify whether a TennCare patient received destruction services at an outside clinic or within your practice during the current benefit period. Clinical intake should include standard prompts regarding recent cryotherapy or surgical destructions performed elsewhere.

3. Implement Alternative Treatment Pathways

When a TennCare member has exhausted their covered destruction frequency for the benefit year, providers must be alerted prior to the encounter. Providers can then evaluate clinically appropriate alternative treatments—such as topical field therapies requiring prescription coverage rather than procedural claims—or initiate plan-specific authorization requests before performing additional physical destructions.

Concrete Workflow Controls to Implement This Week

To protect revenue and eliminate preventable denials under both Palmetto GBA and TennCare, implement these four operational controls immediately:

  • Audit Modifier 25 Notes Against Palmetto GBA Guidance: Review ten consecutive charts where an E/M code was billed alongside a biopsy or cryosurgery. Confirm that the chart contains a separate chief complaint, independent physical exam findings, and a discrete medical decision-making process justifying the E/M service.
  • Build a TennCare Destruction Tracker: Create an active registry or automated PM report that tracks the lifetime and rolling 12-month counts of CPT 17000–17111 for all Medicaid managed care patients.
  • Standardize Operative Documentation for Cryotherapy: Ensure providers record the specific anatomic location, diameter, clinical diagnosis, and destruction method (e.g., liquid nitrogen freeze-thaw cycles) for every single lesion treated, rather than using generalized region summaries.
  • Enforce Upfront Eligibility and Prior Authorization Checks: Train intake teams to verify whether specific TennCare MCO policies require prior approval for extensive destructions (CPT 17004) or repeat benign lesion treatments prior to rooming the patient.

If your clinic is struggling with recurring TennCare claim rejections, uncollected lesion destruction charges, or Palmetto GBA compliance concerns, our specialized team can help. Request a free dermatology claims audit to identify hidden billing errors, recover lost revenue, and streamline your practice workflows.

Frequently asked questions

What clinical documentation does Palmetto GBA require to cover benign lesion removal?

Palmetto GBA requires that the medical record explicitly demonstrate medical necessity prior to removal. Covered indications include symptomatic irritation from clothing, recurrent bleeding, intense pain or itching, infection, or functional impairment. Cosmetic removals without functional symptoms are non-covered.

Why do TennCare MCOs routinely deny cryosurgery claims for actinic keratoses?

TennCare MCOs frequently enforce annual or rolling 12-month frequency limits on destruction codes. When a patient exceeds the allotted number of sessions within a benefit period, the payer adjudicates subsequent claims as non-covered service limit exceedances, resulting in zero payment unless prior authorization or an appeal with medical necessity is established.

How should a practice track destruction frequency across different plan years?

Practices should configure their practice management systems with payer-specific rules that flag CPT codes 17000-17004 and 17110-17111. Front-end and clinical teams should maintain a centralized destruction log to verify past utilization within the patient's plan year before scheduling repeat procedures.

When is Modifier 25 permissible alongside a lesion biopsy under Palmetto GBA rules?

Modifier 25 is appropriate only when the clinical documentation substantiates a significant, separately identifiable evaluation and management service above and beyond the usual pre- and post-operative work of the procedure. The E/M must address a distinct problem or a clinical decision to perform a procedure on a new, unmanaged condition.

Primary sources

Coding and coverage rules change. Verify against the source before you bill.

Find your leaked revenue. Free dermatology claims audit — results in 5 business days.